Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Gains from Sales and Divestitures (2016 - 2026)

Neuronetics has reported Gains from Sales and Divestitures over the past 11 years, most recently at $774000.0 for Q1 2026.

  • Quarterly Gains from Sales and Divestitures fell 19.96% to $774000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $774000.0 through Mar 2026, down 19.96% year-over-year, with the annual reading at $1.6 million for FY2025, 8.33% up from the prior year.
  • Gains from Sales and Divestitures was $774000.0 for Q1 2026 at Neuronetics, down from $1.6 million in the prior quarter.
  • Over five years, Gains from Sales and Divestitures peaked at $1.8 million in Q4 2023 and troughed at $318000.0 in Q1 2022.
  • The 5-year median for Gains from Sales and Divestitures is $1.2 million (2024), against an average of $1.1 million.
  • Year-over-year, Gains from Sales and Divestitures skyrocketed 277.75% in 2023 and then decreased 26.23% in 2024.
  • A 5-year view of Gains from Sales and Divestitures shows it stood at $705000.0 in 2022, then surged by 158.58% to $1.8 million in 2023, then fell by 19.69% to $1.5 million in 2024, then increased by 8.33% to $1.6 million in 2025, then crashed by 51.2% to $774000.0 in 2026.
  • Per Business Quant, the three most recent readings for STIM's Gains from Sales and Divestitures are $774000.0 (Q1 2026), $1.6 million (Q4 2025), and $1.3 million (Q3 2025).